| Literature DB >> 33445678 |
Hyeon Jeong Seo1, Jung Eun Park2,3, Seong-Min Choi4,5, Taekyoung Kim5, Soo Hyun Cho4,5, Kyung-Hwa Lee6, Woo Keun Song7, Juhyun Song8, Han-Seong Jeong9, Dong Hyun Kim10, Byeong C Kim1,4,5.
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a rapid accumulation of amyloid β (Aβ) protein in the hippocampus, which impairs synaptic structures and neuronal signal transmission, induces neuronal loss, and diminishes memory and cognitive functions. The present study investigated the impact of neuregulin 1 (NRG1)-ErbB4 signaling on the impairment of neural networks underlying hippocampal long-term potentiation (LTP) in 5xFAD mice, a model of AD with greater symptom severity than that of TG2576 mice. Specifically, we observed parvalbumin (PV)-containing hippocampal interneurons, the effect of NRG1 on hippocampal LTP, and the functioning of learning and memory. We found a significant decrease in the number of PV interneurons in 11-month-old 5xFAD mice. Moreover, synaptic transmission in the 5xFAD mice decreased at 6 months of age. The 11-month-old transgenic AD mice showed fewer inhibitory PV neurons and impaired NRG1-ErbB4 signaling than did wild-type mice, indicating that the former exhibit the impairment of neuronal networks underlying LTP in the hippocampal Schaffer-collateral pathway. In conclusion, this study confirmed the impaired LTP in 5xFAD mice and its association with aberrant NRG1-ErbB signaling in the neuronal network.Entities:
Keywords: Alzheimer’s disease; CA1; NRG1-ErbB4 signaling; hippocampal long-term potentiation; hippocampus
Mesh:
Substances:
Year: 2021 PMID: 33445678 PMCID: PMC7828160 DOI: 10.3390/ijms22020698
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923